Hemostasis and Tissue Sealing Agents Market Expected to Reach Usd 5.2 Billion Globally in 2020

Transparency Market
Research
Hemostasis and Tissue Sealing Agents Market - Global
Industry Analysis, Size, Share, Growth, Trends and
Forecast 2014 - 2020
Published Date
27-01-2015

85 Page Report

Buy Now

Request Sample

Press Release

Hemostasis and Tissue Sealing Agents Market Expected to
Reach USD 5.2 Billion globally in 2020

Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Hemostasis and Tissue Sealing
Agents Market

REPORT DESCRIPTION

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat,
tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during
the surgery. These products play an important role in management of bleeding within the
damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing
agents is witnessing positive growth due to the introduction of technology advanced and cost
effective hemostat and tissue sealing products by key companies. For example, in June 2013,
Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue
adhesive.

The company also offers wide range of hemostasis and tissue sealant products such as
RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of
these products hence drive the market growth. Other factors such as aging population and rising
number surgical procedures further drive the growth of the hemostasis and tissue sealing agents
market globally. For example, according to the World Health Organization (WHO), the number of
people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050.
Aging population will boost the number of people undergoing surgical intervention which would
in turn stimulate the demand of hemostat and tissue sealing...